Skip to main content
FLSC
NASDAQ Energy & Transportation

Frazier Life Sciences SPAC II Closes $75M IPO, Adds $3M Sponsor Placement and $25M Forward Purchase

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Energy
Sentiment info
Neutral
Importance info
7
Price
$10.49
Mkt Cap
$101.491M
52W Low
$10.18
52W High
$10.49
52W Position info
3.0% above low
Off High info
at 52W high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

FLSC is trading near its 52-week low of $10.18 (3.0% above the low) on light trading volume (0.1× avg).

Summary

Frazier Life Sciences Acquisition Corp. II closed its $75 million IPO at $10.00 per share, funded the trust, and added a $3 million sponsor private placement plus a $25 million forward purchase commitment that would fund at the business combination closing.


Key Events · Financing and Capital Events · FLSC

  • IPO Closed at $10.00 Per Share

    7,500,000 Class A ordinary shares sold at $10.00 for $75,000,000 in gross proceeds; shares trade on Nasdaq under FLSC.

  • Trust Funded With $75 Million

    The full $75,000,000 of IPO and private placement proceeds was placed in a U.S. trust account for the benefit of public shareholders.

  • Sponsor Placement Adds $3 Million

    Frazier Life Sciences Holdings II, LLC bought 300,000 Class A shares at $10.00 in a private placement that closed alongside the IPO.

  • Forward Purchase Commitment of $25 Million

    Frazier Life Sciences Public Fund, L.P. committed to buy at least 2,500,000 Class A shares at $10.00, closing concurrently with the initial business combination and subject to its investment committee's approval before a definitive deal is signed.


Analysis · FLSC · Energy & Transportation

The $75 million IPO priced on October 13 is now closed: 7,500,000 Class A shares at $10.00, with the full $75 million sitting in trust for a business combination. Two pieces of capital beyond the public raise matter for the deal math — the sponsor bought 300,000 Class A shares for $3 million in a private placement, and Frazier Life Sciences Public Fund committed to buy at least 2,500,000 Class A shares for $25 million at the closing of the initial business combination, subject to its investment committee's approval before a definitive deal is signed. That forward purchase is the pool of committed equity the team can point to when negotiating a target, and it is not guaranteed: the fund's committee can decline. Underwriters took $9.80 per share now and hold a $0.40 per share deferred discount that is only paid if a business combination closes, so Jefferies is aligned with getting a deal done. The clock is running — the company has 24 months from closing to complete a combination or return the trust to public shareholders.

How filings like this one have moved

In the 30 days to Oct 15, 2026, 28.9% of the 1476 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FLSC was trading at $10.49 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $101.5M. The 52-week trading range was $10.18 to $10.49. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FLSC - Latest Insights

FLSC
Oct 14, 2026, 4:31 PM EDT
Filing Type: 424B4
Importance Score:
7
Price at Filing: $10.29
Real-time Price: $10.49 info
Change: +$0.200 (+2%) info
Market Cap: $101.491M info